1. Wang K., Feng X., Chai L., Cao S., Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metabolism Reviews, 2017, vol. 49, no. 2, pp. 139-157. https://doi.org/10.1080/03602532.2017.1306544
2. Kumar A., Ekavali E., Chopra K., Mukherjee M., Pottabathini R., Dhull D. K. Current knowledge and pharmacological profle of berberine: An update. European Journal of Pharmacology, 2015, vol. 761, pp. 288-297. https://doi.org/10.1016/j.ejphar.2015.05.068
3. Imanshahidi M., Hosseinzadeh H. Berberis vulgaris and berberine: An update review. Phytotherapy Research, 2016, vol. 30, no. 11, pp. 1745-1764. https://doi.org/10.1002/ptr.5693
4. Li J., Pan Y., Kan M., Xiao X., Wang Y., Guan F., Zhang X., Chen L. Hepatoprotective effects of berberine on liver fbrosis via activation of AMP-activated protein kinase. Life Sciences, 2014, vol. 98, no. 1, pp. 24-30. https://doi.org/10.1016/j.lfs.2013.12.211
5. Zverinsky I. V., Melnichenko N. G., Poplavsky V. A., Sutsko I. P., Telegin P. G., Shlyahtun A. G. The effect of berberine administration to rats on the functional state of liver after common bile duct ligation. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2012, vol. 6, no. 2, pp 159-163 https://doi.org/10.1134/S1990750812020163
6. Zverinskii I. V., Zverinskaya N. G., Sut’ko I. P., Telegin P. G., Shlyakhtun A. G. Effects of berberine on the recovery of rat liver xenobiotic-metabolizing enzymes after partial hepatectomy. Biomeditsinskaya khimiya = Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2015, vol. 61, no. 3, pp. 381-383 (in Russian).
7. Liu C.-S., Zheng Y.-R., Zhang Y.-F., Long X.-Y. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia, 2016, vol. 109, pp. 274-282. https://doi.org/10.1016/j.ftote.2016.02.001
8. Liu Y.-T., Hao H.-P., Xie H.-G., Lai L., Wang Q., Liu C.-X., Wang G.-J. Extensive intestinal frst-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metabolism and Disposition, 2010, vol. 38, no. 10, pp. 1779-1784. https://doi.org/10.1124/dmd.110.033936
9. Vergun O., Borisevich S., Kamyschnikov V. Acute paracetamol intoxication, diagnostics. Laboratornaya diagnostika. Vostochnaya Evropa = Laboratory diagnostics. Eastern Europe, 2015, no. 2 (14), pp. 113-118 (in Russian).
10. Ghanem C. I., Pérez M. J., Manautou J. E., Mottino A. D. Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacological Research, 2016, vol. 109, pp. 119-131. https://doi.org/10.1016/j.phrs.2016.02.020
11. Granik V. G. Toxicology of drugs. Moscow, Vuzovskaya kniga Publ., 2009. 440 p. (in Russian).
12. Ghosh P. K., Murthy R. S. Mic roemulsions: a potential drug delivery system. Current Drug Delivery, 2006, vol. 3, no. 2, pp. 167-180. https://doi.org/10.2174/156720106776359168
13. Gursoy R. N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy, 2004, vol. 58, no. 3, pp. 173-182. https://doi.org/10.1016/j.biopha.2004.02.001
14. Cerpnjak K., Zvonar A., Gašperlin M., Vrečer F. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharmaceutica, 2013, vol. 63, no. 4, pp. 427-445. https://doi.org/10.2478/acph-2013-0040
15. Ellman G. L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 1959, vol. 82, no. 1, pp. 70-71. https://doi.org/10.1016/0003-9861(59)90090-6
16. Sedlak J., Lindsay R. H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry, 1968, vol. 25, pp. 192-205. https://doi.org/10.1016/0003-2697(68)90092-4
17. Carlberg I., Mannervick B. Glutathione reductase. Methods in Enzymology, 1985, vol. 113, pp. 484-490. https://doi.org/10.1016/S0076-6879(85)13062-4
18. Habig W. J., Pabst M. J., Jacoby W. B. Glutathione S-transferase, the frst enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 1974, vol. 249, no. 22, pp. 7130-7139.
19. Martinez J. I., Launay J.-M., Dreux C. A sensitive fluorimetric microassay for the determination of glutathione peroxidase activity. Application to human blood platelets. Analytical Biochemistry, 1979, vol. 98, no. 1, pp. 154-159. https://doi.org/10.1016/0003-2697(79)90720-6
20. Tamura T., Stadtman T. C. A new selenoprotein from human lung adenocarcinoma cells: purifcation, properties and thioredoxin activity. Proceedings of the National Academy of Sciences, 1996, vol. 93, no. 3, pp. 1006-1011. https://doi.org/10.1073/pnas.93.3.1006
21. Balamir A. NADP-linked isocitrate dehydrogenase from beef liver: a new method of purifcation and the effect of metal ion cofactor on its stability. Biochemical Medicine, 1983, vol. 29, no. 2, pp. 194-206. https://doi.org/10.1016/0006-2944(83)90040-6
22. Glock G. E., McLean P. Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liver. Biochemical Journal, 1953, vol. 55, no. 3, pp. 400-408. https://doi.org/10.1042/bj0550400
23. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 1951, vol. 193, no. 1, pp. 265-275.
24. Zhang P., Ma D., Wang Y., Zhang M., Qiang X., Liao M., Liu X., Wu H., Zhang Y. Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice. Food and Chemical Toxicology, 2014, vol. 74, pp. 225-232. https://doi.org/10.1016/j.fct.2014.10.005
25. Forrest J. A., Clements J. A., Prescott L. F. Clinical pharmacokinetics of paracetamol. Clinical Pharmacokinetics, 1982, vol. 7, no. 2, pp. 93-107. https://doi.org/10.2165/00003088-198207020-00001